Further inspection of these statistics reveals a slightly different perspective, however, especially with regard to the type of jobs that are being created in the contemporary employment market. While the U.S. economy added an estimated 175,000 new jobs in May, for example, the majority of these were low paid, entry-level positions that delivered less than a living wage.
Maximizing Your Earning Potential in the Current Job Market
With youth unemployment in the United States also remaining uncomfortably high at 16.2%, it is clear that the job market poses considerable challenges to the majority of social demographics. The issues facing college graduates and America's unemployed youth offer a fascinating insight into the mindset of employers, however, as a lack of practical work experience often undermines any academic qualifications that candidates have acquired. With this in mind, entry-level jobs actually offer individuals a unique opportunity to maximize their current earning potential as they gather valuable industry experience. The key is to identify the most rewarding entry-level jobs, both in terms of salary and future career prospects. Consider the following options:
10 Best International Stocks To Invest In 2015: Osaka Gas Co Ltd (OSA)
OSAKA GAS CO., LTD. is primarily engaged in gas business. It operates in four business segments. The Gas segment is involved in the production, supply and sale of gas, the sale of gas equipment and housing equipment, the construction of gas piping works, the maintenance and inspection of gas equipment. The Liquefied Petroleum Gas (LPG), Electric and Other Energy segment is engaged in the sale of LPG and the supply of electricity. The Oversea Energy segment is engaged in the leasing of liquefied natural gas (LNG) tankers, the oil and gas-related development and investment, the research and investment of energy supply business. The Environment and Non-energy segment is involved in the development, leasing, management and subdivision of real estates, the leasing and maintenance of automobiles, the manufacture and sale of fine materials and carbon materials, the staff dispatching business, the credit and insurance agency business and the operation of sports facilities. Advisors' Opinion:- [By Damian Illia]
The company is also aware that its ability to sell non-invase treatment products relies largely on the willingness of third parties to pay for treatment. Therefore, it not only focuses on developing devices to treat sleep apnea and other respiratory problem. It also does on increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated SDB as well as educating caregivers about therapy options. It is estimated that SDB affects 20 percent of the adult population and that 90 percent who have obstructed sleep apnea (OSA) still are and most likely will remain undiagnosed and untreated. The company has therefore created a number of foundations and funds primary care physician programs to educate doctors on SDB. On the other hand, diagnosed COPD patients in America are around 12 million people, but is is estimated that another 12 milion may have the disease and hasn't been diagnosed yet. Also, ResMed looks forward to capture those patients who formerly balked at costly, uncomfortable testing in a sleep lad through at-home sleep apnea testing. What this all really means actually, is that ResMed's potential markets have not really been penetrated and that the growth prospects for the coming years is huge.
Hot Consumer Service Companies To Watch For 2014: Nash-Finch Company(NAFC)
Nash-Finch Company operates as a wholesale food distributor in the United States. The company?s Military segment distributes grocery products to the United States military commissaries and exchanges in the United States and the District of Columbia, Europe, Puerto Rico, Cuba, the Azores, Egypt, and Bahrain. Its Food Distribution segment sells and distributes various branded and private label grocery products and perishable food products to approximately 1,500 independent retail locations through its 14 distribution centers. This segment also provides various services, including promotional, advertising, and merchandising programs; installation of computerized ordering, receiving, and scanning systems; retail equipment procurement assistance; accounting, budgeting, and payroll contract services; consumer and market research; remodeling and store development services; supply chain through Internet services; and securing existing grocery stores. The company?s Retail segment operates corporate-owned grocery stores under the Sun Mart, Econofoods, AVANZA, Family Thrift Center, Pick ?n Save, Family Fresh Market, Prairie Market, Saver?s Choice, Wally?s Supermarkets, and Wholesale Food Outlet banners primarily in the states of Colorado, Iowa, Minnesota, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. This segment?s conventional grocery stores offer a range of grocery products and services, such as fresh meat counters, delicatessens, bakeries, eat-in cafes, pharmacies, banks, and floral departments, as well as provide check cashing, fax services, and money transfer services. As of December 31, 2011, the company served 93 retail stores operating under the IGA banner and 50 retail stores under the Food Pride banner; and operated 43 conventional supermarkets, 1 AVANZA grocery store, 1 Wholesale Food Outlet grocery store, and 1 Saver?s Choice store. Nash-Finch Company was founded in 1885 and is based in Minneapolis, Minnesota.
Advisors' Opinion:- [By Alex Planes]
Sysco has avoided the margin compression suffered by chicken producers Tyson (NYSE: TSN ) and Cal-Maine Foods (NASDAQ: CALM ) and which was more deeply felt by smaller food-service operator Nash-Finch (NASDAQ: NAFC ) . (It is omitted from this chart due to its drop into outright negative operating margin territory (a decline of roughly 250% in two years.) However, fellow food-service company United Natural Foods (NASDAQ: UNFI ) has actually improved its margins, and restaurant chains both large and small (well, mid-size) have done an admirable job of holding the margin line in the face of rising input costs. So it appears that scale alone isn't enough to help Sysco outrun the rising costs of its products.
- [By Jeremy Bowman]
What: Shares of Nash-Finch (NASDAQ: NAFC ) and Spartan Stores (NASDAQ: SPTN ) jumped as much as 16% and 15%, respectively, after Spartan said it would buy Nash-Finch, primarily for its military stores.
Hot Consumer Service Companies To Watch For 2014: Maxim Integrated Products Inc.(MXIM)
Maxim Integrated Products, Inc. engages in designing, developing, manufacturing, and marketing various linear and mixed-signal integrated circuits worldwide. The company also provides various high-frequency process technologies and capabilities for use in custom designs. It primarily serves industrial, communications, consumer, and computing markets. The company markets its products through a direct-sales and applications organization, as well as through its own and other unaffiliated distribution channels. Maxim Integrated Products, Inc. was founded in 1983 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By rusticnomad]
Maxim Integrated (MXIM) didn't do very well last quarter as its revenue declined. This decline was anticipated by management, as its consumer business was facing seasonal weakness. However, the gains from the initial ramp of a new smartphone at its largest customer arrested the decline.
Hot Consumer Service Companies To Watch For 2014: Coca-Cola Enterprises Inc. (CCE)
Coca-Cola Enterprises Inc. produces, distributes, and markets non-alcoholic beverages in Europe. It provides a range of beverage categories, including energy drinks, still and sparkling waters, juices, sports drinks, fruit drinks, coffee-based beverages, and teas. The company primarily offers its products under Coca-Cola, Diet Coke/Coke light, Fanta, Coca-Cola Zero, Capri Sun, Schweppes, Sprite, Chaudfontaine, MinuteMaid, and Dr. Pepper brands. It provides its products to customers and consumers through licensed territory agreements in Belgium, continental France, Great Britain, Luxembourg, Monaco, the Netherlands, Norway, and Sweden. Coca-Cola Enterprises Inc. was founded in 1986 and is based in Atlanta, Georgia.
Advisors' Opinion:- [By Ben Rooney]
There have been rumors that SodaStream could partner with a larger beverage company after Coca-Cola (CCE) took a significant stake in Keurig Green Mountain (GMCR), which is working on its own at-home soda machine.
- [By Marc Bastow]
Non-alcoholic beverage distributor Coca-Cola Enerprises (CCE) raised its quarterly dividend 25% to 25 cents per share, payable on Mar. 20 to shareholders of record as of Mar. 7.
CCE Dividend Yield: 2.25%
Hot Consumer Service Companies To Watch For 2014: Myriad Genetics Inc (MYGN)
Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis. The Company uses this information to guide the development of new molecular diagnostic tests that are designed to assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to ensure optimal treatment (personalized medicine), or assess a patient's risk of disease progression and disease recurrence (prognostic medicine).
As of June 30, 2012, the Company had launched nine commercial molecular diagnostic tests. The Company markets these tests through its own approximate 385-person sales force in the United States. The Company also markets its BRACAnalysis, COLARIS, and COLARIS AP tests through its own European sales force and have entered into marketing collaborations with other organizations in selected Latin American, European and Asian countries. The Company also generates revenue by providing companion diagnostic services to the pharmaceutical, and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.
Molecular Diagnostic Tests
The Company's molecular diagnostic tests are designed to analyze genes, their mutations, expression levels and proteins to assess an individual's risk for developing disease later in life, determine a patient's likelihood of responding to a particular drug, assess a patient's risk of disease progression and disease recurrence and measure a patient's exposure to drug therapy to ensu! re optimal dosing and reduced drug toxicity. The Company's BRACAnalysis test is a analysis of the BRCA1 and BRCA2 genes for assessing a woman's risk of developing hereditary breast and ovarian cancer. BRACAnalysis accounted for 81.7% of the Company's total revenue during the fiscal year ended June 30, 2012. Its The Company's COLARIS test is an analysis of the MLH1, MSH2, MSH6 and PMS2 genes for assessing a person's risk of developing colorectal cancer or uterine cancer.
The Company's COLARIS AP test detects mutations in the APC and MYH genes, which cause a colon polyp-forming syndrome known as Familial Adenomatous Polyposis (FAP), a more common variation of the syndrome known as attenuated FAP, and the MYH-associated polyposis signature (MAP). The Company's MELARIS test analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma. The Company's OnDose test is a nanoparticle immunoassay that is designed to assist oncologists in optimizing 5-FU (fluorouracil) anti-cancer drug therapy in colon cancer patients on an individualized basis. The Company's PANEXIA test is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. The Company's PREZEON test is an immunohistochemistry test that analyzes the PTEN gene and assesses loss of PTEN function in many cancer types.
The Company's Prolaris test is a 46-gene molecular diagnostic assay that assesses whether a patient is likely to have a slow growing, indolent form of prostate cancer that can be safely monitored through active surveillance, or a more aggressive form of the disease that would warrant aggressive intervention, such as a radical prostatectomy or radiation therapy. The Company's TheraGuide 5-FU test analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of toxicity to 5-FU (fluorouracil) anti-cancer drug therapy.
Companion Diagnostic Services and Other Revenue
! Through M! yriad RBM Inc., the Company provides biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical researches industries utilizing its multiplexed immunoassay technology. The Company's technology enables the Company to screen large sets of clinical samples from both diseased and non-diseased populations against the Company's menu of biomarkers. The Company's companion diagnostic services consist of Multi-Analyte Profile (MAP), Multiplexed Immunoassay Kits and TruCulture.
The Company has compiled a library of over 550 individual human and rodent immunoassays for use in its multi-analyte profile (MAP) testing services. The Company has also developed RodentMAP, a panel for use in pre-clinical animal studies and OncologyMAP, which measures cancer-related proteins to assists researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring. The Company has developed multiplexed immunoassay kits that enable its customers to leverage its technology services with their in-house capabilities. The Company's internally developed multiplexed immunoassay kits include all of the components necessary for a customer to perform a test on their own Luminex instrument. TruCulture is a simple, self-contained whole blood culture that can be deployed to clinical sites around the world for acquiring cell culture data without specialized facilities or training.
Advisors' Opinion:- [By Lisa Levin]
Myriad Genetics (NASDAQ: MYGN) surged 12.89% to $39.68. The volume of Myriad Genetics shares traded 286% higher than normal. The Centers for Medicare & Medicaid Services updated pricing for the sequencing of the BRCA1 and BRCA2 genes.
Hot Consumer Service Companies To Watch For 2014: Rapier Gold Inc (RPR)
Rapier Gold Inc. is a Canada-based gold focused exploration company. On March 12, 2013, the Company closed a share purchase agreement with two subsidiaries of Rio Tinto plc, which control rights to all non-talc minerals on mineral claims, Pen Gold North Project. The Pen Gold North Project is approximately 5,600 hectares in area and some of the claims are held through a lease and sublease with IMERYS. The combination of Pen Gold North and Pen Gold South properties comprise 16,448 hectares (approximately 160 square kilometers) located on the western extension of the Porcupine-Destor Deformation (Fault) Zone. The Company has executed the license and option agreement with Rogue Iron Corp. to explore for gold on the Pen Gold South property, which totals approximately 10,848 hectares, with an option to purchase those claims. These claims are part of a contiguous block with the Pen Gold North claims. Advisors' Opinion:- [By Holly LaFon]
Whitney George is Director of Investments, Managing Director, and a Portfolio Manager of Royce & Associates, LLC, investment advisor to The Royce Funds. He serves as portfolio manager for Royce Premier Fund (RPR), Royce Low-Priced Stock Fund (RLP), Royce Global Value Fund (RGV), Royce SMid-Cap Value Fund (RSV), and Royce Focus Trust (FUND). He also serves as assistant portfolio manager for Royce Micro-Cap Fund (RMC), Royce Value Fund (RVV), Royce Value Plus Fund (RVP), Royce Focus Value Fund (RFV), and Royce Capital Fund ��Micro-Cap Portfolio (RCM). Mr. George's thoughts in this interview concerning the stock market are solely his own and, of course, there can be no assurance with regard to future market movements.
No comments:
Post a Comment